EX-10.1




 Exhibit 10.1 

CATALYST BIOSCIENCES, INC. 

CONSULTING AGREEMENT 
 This
Consulting Agreement (this “Agreement”) is entered into as of 13 October 2021 to be effective upon the date of termination of your employment (the “Effective Date”) between Catalyst Biosciences, Inc., a
Delaware corporation (“Company”), and Clinton Musil (“Consultant”). Company desires to retain Consultant to perform certain consulting activities as described below, and Consultant desires to serve as a consultant
to Company and perform such activities under the terms of this Agreement. 
 NOW, THEREFORE, Consultant and Company agree as follows: 

1.    SERVICES AND COMPENSATION 

(a)    Consultant agrees to act as a consultant to Company with respect to such matters and projects as are mutually
agreed from time to time by and between Consultant and Company, and to perform the services described on Exhibit A hereto (collectively, the “Services”). 

(b)    Company agrees to pay Consultant the compensation set forth in Exhibit A hereto for the
performance of the Services. 
 2.    CONFIDENTIALITY 

(a)    “Confidential Information” means any proprietary information, technical data, trade secrets or know-how, including, but not limited to, research and product plans, products, services, markets, developments, inventions, processes, formulas, technology, marketing, finances or other business information
disclosed to Consultant by Company either directly or indirectly in writing, orally or otherwise. Confidential Information also includes all Inventions (as defined below) and any other information or materials generated in connection with the
Services. 
 (b)    Consultant shall not, during or subsequent to the term of this Agreement, use any Confidential
Information for any purpose whatsoever other than the performance of the Services on behalf of Company, or disclose Confidential Information to any third party. Consultant agrees that Confidential Information shall remain the sole property of
Company. Consultant further agrees to take all reasonable precautions to prevent any unauthorized disclosure or use of Confidential Information. Notwithstanding the above, Consultant’s obligation under this Section 2(b) relating to
Confidential Information shall not apply to information which (i) is known to Consultant at the time of disclosure to Consultant by Company as evidenced by written records of Consultant, (ii) has become publicly known and made generally
available through no wrongful act of Consultant, or (iii) has been rightfully received by Consultant from a third party authorized to make such disclosure. 

(c)    Consultant agrees that Consultant will not, during the term of this Agreement, improperly use or disclose to
Company any proprietary information or trade secrets of any former or current employer or other person or entity to which Consultant has a duty to keep in confidence such information and that Consultant will not bring onto the premises of Company
any unpublished document or proprietary information belonging to such employer, person or entity unless consented to in writing by the same. Consultant will indemnify Company and hold it harmless from and against all claims, liabilities, damages and
expenses, including reasonable attorneys’ fees and costs of suit, arising out of or in connection with any violation or claimed violation by Company of such third party’s rights resulting in whole or in part from Company’s use of the
work product of Consultant under this Agreement. 











 (d)    Consultant recognizes that Company has received and in the future
will receive from third parties their confidential or proprietary information subject to a duty on Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. Consultant agrees that
Consultant owes Company and such third parties, during the term of this Agreement and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation
or to use it except as necessary in carrying out the Services for Company consistent with Company’s agreement with such third party. 

(e)    Upon the termination of this Agreement, or upon Company’s earlier request, Consultant will deliver to Company
all Confidential Information and Company’s property relating thereto and all tangible embodiments thereof, in Consultant’s possession or control. 

(f)    DTSA Notice. Consultant acknowledges receipt of the following notice pursuant to 18 U.S.C. § 1833(b)(1)
(Defend Trade Secrets Act): 
 An individual shall not be held criminally or civilly liable under any federal or state trade secret law for
the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law. An individual shall not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. An individual who
files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any
document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order. 

3.    OWNERSHIP 

(a)    Consultant hereby irrevocably assigns to Company all right, title and interest in and to any information
(including, without limitation, business plans and/or business information), technology, know-how, materials, notes, records, designs, ideas, inventions, improvements, devices, developments, discoveries,
compositions, trade secrets, processes, methods and/or techniques, whether or not patentable or copyrightable, that are conceived, reduced to practice or made by Consultant alone or jointly with others in the course of performing the Services or
through the use of Confidential Information (collectively, “Inventions”). 
 (b)    Consultant agrees
to sign, execute and acknowledge or cause to be signed, executed and acknowledged without cost, but at the expense of Company, any and all documents and to perform such acts as may be necessary, useful or convenient for the purposes of perfecting
the foregoing assignments and obtaining, enforcing and defending intellectual property rights in any and all countries with respect to Inventions. It is understood and agreed that Company or Company’s designee shall have the sole right, but not
the obligation, to prepare, file, prosecute and maintain patent applications and patents worldwide with respect to Inventions. 

  
 -2- 












 (c)    Upon the termination of this Agreement, or upon Company’s
earlier requests, Consultant will deliver to Company all property relating to, and all tangible embodiments of, Inventions in Consultant’s possession or control. 

(d)    Consultant agrees that if, in the course of performing the Services, Consultant incorporates into any Invention
developed hereunder any invention, improvement, development concept, discovery or other proprietary subject matter owned by Consultant or in which Consultant has an interest (“Item”), Consultant will inform Company in writing
thereof, and Company is hereby granted and shall have a non-exclusive, royalty-free, perpetual, irrevocable, worldwide license to make, have made, modify, reproduce, display, use and sell such Item as part of
or in connection with the exploitation of such Invention. 
 (e)    Consultant agrees that if Company is unable because
of Consultant’s unavailability, mental or physical incapacity, or for any other reason, to secure Consultant’s signature to apply for or to pursue any application or registration for any intellectual property rights covering any Invention,
then Consultant hereby irrevocably designates and appoints Company and its duly authorized officers and agents as Consultant’s agent and attorney-in-fact, to act
for and in Consultant’s behalf to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of such intellectual property rights thereon with the same legal force and effect as if
executed by Consultant. 
 4.    REPORTS. Consultant agrees, from time to time during the term of this Agreement,
to keep Company advised as to Consultant’s progress in performing the Services and, as reasonably requested by Company, prepare written reports with respect thereto. It is understood that the time required in the preparation of such written
reports shall be considered time devoted to the performance of the Services by Consultant. All such reports prepared by Consultant shall be the sole property of Company. 

5.    TERM AND TERMINATION 

(a)    This Agreement will commence on the Effective Date and will continue until the earlier of 31 December 2021, or
termination as provided below. 
 (b)    Either party may terminate this Agreement upon prior written notice thereof to
the other party. 
 (c)    Either party may terminate this Agreement upon material breach by the other party provided
that the non-breaching party shall provide written notice of such breach and an opportunity to cure such breach (if curable) for a period of thirty (30) days. 

(d)    Upon termination of this Agreement, all rights and duties of the parties hereunder shall cease except: 

(i)    Company shall be obliged to pay, within thirty (30) days after receipt of Consultant’s final statement,
all amounts owing to Consultant for unpaid Services completed by Consultant and related expenses, if any, in accordance with the provisions of Section 1 hereof, and 

(ii)    Sections 2, 3, 5(d), 6, 7 and 9 shall survive termination of this Agreement. 

6.    INDEPENDENT CONTRACTOR. Nothing in this Agreement shall in any way be construed to constitute Consultant as an
agent, employee or representative of Company, but Consultant shall perform the Services as an independent contractor. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant
pursuant to this Agreement. 

  
 -3- 












 7.    ARBITRATION AND EQUITABLE RELIEF. Company and Consultant
agree that any dispute or controversy arising out of, in relation to, or in connection with this Agreement, or the making, interpretation, construction, performance or breach hereof, shall be finally settled by binding arbitration in San Francisco,
California under the then current rules of the American Arbitration Association by one (1) arbitrator appointed in accordance with such rules. The arbitrator may grant injunctive or other relief in such dispute or controversy. The decision of
the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court of competent jurisdiction. The parties agree that, any provision of applicable law
notwithstanding, they will not request, and the arbitrator shall have no authority to award, punitive or exemplary damages against either party. The costs of the arbitration, including administrative and arbitrator’s fees, shall be shared
equally by the parties. Each party shall bear the cost of its own attorneys’ fees and expert witness fees. 

  
 -4- 












 8.    CONFLICTING OBLIGATIONS. Consultant hereby certifies that he
or she has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude Consultant from complying with the provisions hereof, and further certifies that Consultant will not enter
into any such conflicting agreement during the term of this Agreement. Subject to written waivers that may be provided by the Company upon request, which shall not be unreasonably withheld, Consultant agrees that, during the term of this Agreement,
Consultant will not directly or indirectly (i) provide any services in the Field of Interest to any other business or commercial entity, (ii) provide any services for any company that is competitive with the Company and shall list in
Exhibit B hereto any other companies for whom Consultant is providing services (“Outside Companies”), or (iii) participate in the formation of any business or commercial entity in the Field of Interest or otherwise
competitive with the Company. The “Field of Interest” means the research, development, manufacturing or commercialization of human Factor VIIa or Factor IX products, or varients thereof, or of complement-related products or product
candidates that would compete with products or product candidates that the Company has in development as of the date of the Effective Date. Without limiting the foregoing, Consultant agrees to use his or her best efforts (A) to segregate
Consultant’s Services performed under this Agreement from Consultant’s work done for the Outside Companies so as to minimize any questions of disclosure of, or rights under, any inventions, (B) to notify the CEO of the Company if at
any time the Consultant believes that such questions may result from his or her performance under this Agreement and (C) to assist the Company in fairly resolving any questions in this regard which may arise. The Services performed hereunder
will not be conducted on time that is required to be devoted to any other third party. The Consultant shall not use the funding, resources and facilities of any other third party, without the prior written consent of the Company, to perform Services
hereunder and shall not perform the Services hereunder in any manner that would give any third party rights or access to the product of such Services. 

9.    GENERAL. This Agreement (together with the Exhibits hereto) is the sole agreement and understanding between
Company and Consultant concerning the subject matter hereof, and it supersedes all prior agreements and understandings with respect to such matter. Any required notice shall be given in writing by customary means with receipt confirmed at the
address of each party set forth below, or to such other address as either party may substitute by written notice to the other. Consultant shall not subcontract any portion of Consultant’s duties under this Agreement without the prior written
consent of Company. Neither this Agreement nor any right hereunder or interest herein may be assigned or transferred by Consultant without the express written consent of Company. Company may assign this Agreement to any entity that succeeds to
substantially all of the business or assets of Company. This Agreement shall be governed by the laws of the State of California, without reference to its conflicts of law principles. This Agreement may only be amended or modified by a writing signed
by both parties. Waiver of any term or provision of this Agreement or forbearance to enforce any term or provision by either party shall not constitute a waiver as to any subsequent breach or failure of the same term or provision or a waiver of any
other term or provision of this Agreement. In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect
without said provision, provided that no such severability shall be effective if it materially changes the economic benefit of this Agreement to either Company or Consultant. 

  
 -5- 












 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective
Date. 
  

									
	CATALYST BIOSCIENCES, INC.	 		 	
					
	By:	 	/s/ Nassim Usman, Ph.D.	 		 		 	/s/ Clinton Musil
					
	Print Name:	 	Nassim Usman, Ph.D.	 		 		 	Clinton Musil
					
	Title:	 	President & CEO	 		 		 	

 CATALYST BIOSCIENCES, INC. 

CONSULTING AGREEMENT